From the 1950s to 1970s, discovery of enzymes began by identifying new chemical reactions within cell-free extracts, but ...

Lynk Pharmaceuticals has reported another phase 3 win in China for its next-gen JAK inhibitor, this time hitting skin clearance goals among patients with eczema. | Lynk Pharmaceuticals has reported ...

Key opportunities in the prostate cancer market include innovation in androgen receptor degraders, radiopharmaceuticals, and immune-targeted therapies. Strategic collaborations and acquisitions ...

MONTREAL, TORONTO and VANCOUVER, BC, March 4, 2026 /CNW/ – adMare BioInnovations is proud to announce the launch of ...

Whey protein can help you build muscle, maintain a healthy weight, and more. Here's what to know about whey protein isolate, ...

Pharming uses living organisms as bioreactors for cheaper, sustainable drug production, but requires navigating complex IP and regulatory landscapes.

Welcome to the Nuvation Bio Fourth Quarter and Full Year 2025 Earnings Conference Call. Earlier today, we released financia ...

The chondrosarcoma market is anticipated to increase during the forecast period (2026--2036), owing to improved diagnosis, treatment advancements, increased awareness, the launch of emerging therapies ...

Topline data of investigator‑initiated study at the University of Minnesota and City of Hope demonstrates 86% overall response rate (OR), including 57% ...

Topline data of investigator-initiated study at the University of Minnesota and City of Hope demonstrates 86% overall response rate (OR), including 57% complete response ...

Top-Line Data from Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis Expected by Year-End 2026 –– Raised Proceeds of $200 ...